etomidate

Also known as Amidate®, D-etomidate, R 16659, (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester, (+)-ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate, R-(+)-ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate, (R)-(+)-1-(alpha-methylbenzyl)imidazole-5-carboxylic acid ethyl ester, (+)-etomidate

Etomidate, sold under the brand name Amidate, is a short-acting intravenous anaesthetic agent used for the induction of general anaesthesia and sedation for short procedures such as reduction of dislocated joints, tracheal intubation, cardioversion and electroconvulsive therapy. It was developed at Janssen Pharmaceutica in 1964 and was introduced as an intravenous agent in 1972 in Europe and in 1983 in the United States.